International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 6 , ISSUE 2 ( May-August, 2015 ) > List of Articles


New Insights into Infertility Associated with Polycystic Ovarian Syndrome

Praveena Joglekar Pai, Parama Sahoo

Citation Information : Pai PJ, Sahoo P. New Insights into Infertility Associated with Polycystic Ovarian Syndrome. Int J Infertil Fetal Med 2015; 6 (2):43-50.

DOI: 10.5005/jp-journals-10016-1101

License: CC BY-NC 4.0

Published Online: 01-04-2012

Copyright Statement:  Copyright © 2015; The Author(s).


How to cite this article

Pai PJ, Sahoo P, Kumar P. New Insights into Infertility Associated with Polycystic Ovarian Syndrome. Int J Infertil Fetal Med 2015;6(2):43-50.

PDF Share
  1. The stein-leventhal syndrome: a curable form of sterility. N Engl J Med 1958;259:420-423.
  2. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992. p. 377-384.
  3. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.
  4. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005;83(5):1343-1346.
  5. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006 Nov; 91(11):4237-4245.
  6. Evidence-based methodology workshop on polycystic ovary syndrome 3–5 Dec, 2012. Executive summary at
  7. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol (Oxf) 2007;67(6):811-815.
  8. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18(5):813-823.
  9. ESE PCOS special interest group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014 Oct;171(4):P1-29.
  10. Polycystic ovarian syndrome: diagnosis and management. Clinical Medicine and Research 2004;2(1):13-27.
  11. Recommendations for investigation of hyperandrogenism. Ann Endocrinol (Paris) 2010 Feb;71(1):2-7.
  12. Menstrual disturbances in various thyroid diseases. Endocr J 2010;57(12):1017-1022.
  13. Correlation of prolactin and thyroid hormone concentration with menstrual patterns in infertile women. J Reprod Infertil 2009 Oct;10(3):207-212.
  14. Hyperprolactinemia. J Hum Reprod Sci 2013;6(3):168-175.
  15. LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea. Reprod Biomed Online 2008 Jun;16(6):765-771.
  16. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997;82(11):3728-3733.
  17. The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome. Clin Biochem Rev 2007;28(3):79-92.
  18. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297(6655):1024-1026.
  19. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336(8724): 1141-1144.
  20. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 1997;12(11):2359-2365.
  21. Anti-mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012 Aug;27(8):2494-2502.
  22. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011 Nov;26(11):3123-3129.
  23. The prevalence of polycystic ovary syndrome in a normal population according to the rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 2014 Apr;29(4):791-801.
  24. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20(3):370-385.
  25. Polycystic ovary syndrome. Lancet 2007;370(9588):685-697.
  26. Optimal evaluation of the infertile female. Fertil Steril 2006;86(Suppl 5):S264-S267.
  27. Reliability of ovulation tests in infertile women. Obstet Gynecol 2001 Jan;97(1):92-96.
  28. Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol 2010 Mar;26(3):152-160.
  29. Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries? Eur J Obstet Gynecol Reprod Biol 2011 Feb;154(2):177-181.
  30. Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women. Ultrasound Obstet Gynecol 2008 Oct;32(5):700-703.
  31. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013;28(5):1361-1368.
  32. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group* March 2-3, 2007, Thessaloniki, Greece. Hum Reprod 2008;23(3):462-477.
  33. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994 Apr;61(4):598-604.
  34. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011 Feb 16;(2):CD007506.
  35. Treatment of obesity in polycystic ovary syndrome: a position statement of the androgen excess and polycystic ovary syndrome society. Fertil Steril 2009 Dec;92(6):1966-1982.
  36. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2011 Mar-Apr;17(2):171-183.
  37. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007 Oct;107(10):1755-1767. Review.
  38. Optimal management of subfertility in polycystic ovary syndrome. Int J Womens Health 2014 Jun 13;6:613-621.
  39. An RCT of metformin versus orlistat for the management of obese anovulatory women. Hum Reprod 2009 Apr;24(4):966-967.
  40. Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates. J Hum Reprod Sci 2014 Oct-Dec;7(4):255-261.
  41. Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis 2012;8(4):445-449.
  42. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005 Dec;90(12):6364-6369.
  43. Clomiphene citrate-end of an era? A minireview. Hum Reprod 2005;20(8):2043-2051.
  44. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 2003 Nov;18(11):2357-2362.
  45. Induction of ovulation with clomiphene citrate. in: the global library of women's medicine dedicated to the enhancement of women's healthcare. Lib Women's med 2008, DOI: 10.3843/GLOWM. 10237.
  46. Enclomiphene citrate veresus clomiphene citrate for ovulation induction in women with unexplained infertility. Fertility and Sterility, 2013 Sep;100(3):S143.
  47. Comparison of the effect of tamoxifen on endometrial thickness in women with thin endometrium (< 7 mm) undergoing ovulation induction with clomiphene citrate. Fertil Steril 2010;93(6):2091-2093.
  48. Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study. Fertil Steril 2011;95(5):1725-1729.
  49. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014 Jul 10;371(2):119-129.
  50. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. Cooperative Multicenter Reproductive Medicine Network. N Engl J Med 2007 Feb 8;356(6):551-566.
  51. Metformin use in women with polycystic ovary syndrome. Ann Transl Med 2014 Jun;2(6):56.
  52. PCOSMIC: a multi-centre randomized trial in women with polycystic ovary syndrome evaluating metformin for infertility with clomiphene. Hum Reprod 2010 Jul;25(7):1675-1683.
  53. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014 Nov 18;11:CD006105.
  54. Antioxidants for female subfertility. Cochrane Database Syst Rev 2013 Aug 5; 8:CD007807.
  55. Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod 2003;18(2):408-416.
  56. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 2006;29(2):300-305.
  57. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 2003;7(6):151-159.
  58. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol 2012 Jul; 28(7):509-515.
  59. Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol 2014;30(5):359-362.
  60. A pilot double-blind randomised placebo-controlled doseresponse trial assessing the effects of melatonin on infertility treatment (MIART): study protocol. BMJ Open 2014;4(8):e005986.
  61. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrateresistant patients with polycystic ovary syndrome. Fertil Steril 2005 Feb;83(2):367-370.
  62. N-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: a review of reported outcomes. J Pharmacol Pharmacother 2013 Jul-Sep;4(3):187-191.
  63. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol 2012;77(3):343-350.
  64. Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility: a prospective clinical trial. J Hum Reprod Sci 2010 May;3(2):80-84.
  65. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis. Gynecol Endocrinol 2013 Mar;29(3):187-191.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.